Back to mobile site

Keryx Biopharmaceuticals (KERX) March volatility Elevated at 177 into trial results

January 30, 2008 7:10 AM EST Send to a Friend
Keryx Biopharmaceuticals (Nasdaq: KERX) : KERX lead compound, Sulonex (sulodexide oral gelcap) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login